REGN-3048 plus REGN-3051 show promise for treatment or prophylaxis of MERS-CoV infection Feb. 26, 2021
Constant Therapeutics initiates phase II study of TXA-27 in patients with COVID-19 in Israel Feb. 25, 2021
Carragelose lozenges show promising activity against respiratory viruses including SARS-CoV-2 Feb. 25, 2021
Janssen opens phase III study of rilematovir in neonates, infants and children with RSV infection Feb. 25, 2021
RSS